124 related articles for article (PubMed ID: 11558151)
1. [Involvement of glial glutamate transporters in morphine dependence and naloxone-precipitated withdrawal].
Nakagawa T
Yakugaku Zasshi; 2001 Sep; 121(9):671-7. PubMed ID: 11558151
[TBL] [Abstract][Full Text] [Related]
2. Involvement of glial glutamate transporters in morphine dependence.
Nakagawa T; Satoh M
Ann N Y Acad Sci; 2004 Oct; 1025():383-8. PubMed ID: 15542740
[TBL] [Abstract][Full Text] [Related]
3. Changes in the expression of glial glutamate transporters in the rat brain accompanied with morphine dependence and naloxone-precipitated withdrawal.
Ozawa T; Nakagawa T; Shige K; Minami M; Satoh M
Brain Res; 2001 Jun; 905(1-2):254-8. PubMed ID: 11423104
[TBL] [Abstract][Full Text] [Related]
4. Facilitation of morphine withdrawal symptoms and morphine-induced conditioned place preference by a glutamate transporter inhibitor DL-threo-beta-benzyloxyaspartate in rats.
Sekiya Y; Nakagawa T; Ozawa T; Minami M; Satoh M
Eur J Pharmacol; 2004 Feb; 485(1-3):201-10. PubMed ID: 14757142
[TBL] [Abstract][Full Text] [Related]
5. Effect of gene transfer of GLT-1, a glutamate transporter, into the locus coeruleus by recombinant adenoviruses on morphine physical dependence in rats.
Ozawa T; Nakagawa T; Sekiya Y; Minami M; Satoh M
Eur J Neurosci; 2004 Jan; 19(1):221-6. PubMed ID: 14750980
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer of GLT-1, a glutamate transporter, into the nucleus accumbens shell attenuates methamphetamine- and morphine-induced conditioned place preference in rats.
Fujio M; Nakagawa T; Sekiya Y; Ozawa T; Suzuki Y; Minami M; Satoh M; Kaneko S
Eur J Neurosci; 2005 Dec; 22(11):2744-54. PubMed ID: 16324108
[TBL] [Abstract][Full Text] [Related]
7. Morphine withdrawal increases glutamate uptake and surface expression of glutamate transporter GLT1 at hippocampal synapses.
Xu NJ; Bao L; Fan HP; Bao GB; Pu L; Lu YJ; Wu CF; Zhang X; Pei G
J Neurosci; 2003 Jun; 23(11):4775-84. PubMed ID: 12805317
[TBL] [Abstract][Full Text] [Related]
8. Possible involvement of the locus coeruleus in inhibition by prostanoid EP(3) receptor-selective agonists of morphine withdrawal syndrome in rats.
Nakagawa T; Masuda T; Watanabe T; Minami M; Satoh M
Eur J Pharmacol; 2000 Mar; 390(3):257-66. PubMed ID: 10708732
[TBL] [Abstract][Full Text] [Related]
9. Ionotropic glutamatergic neurotransmission in the ventral tegmental area modulates DeltaFosB expression in the nucleus accumbens and abstinence syndrome in morphine withdrawal rats.
Wang HL; Xiang XH; Guo Y; Wu WR; Cao DY; Wang HS; Zhao Y
Eur J Pharmacol; 2005 Dec; 527(1-3):94-104. PubMed ID: 16303124
[TBL] [Abstract][Full Text] [Related]
10. Presynaptic dopaminergic function in the nucleus accumbens following chronic opiate treatment and precipitated withdrawal.
Ghosh S; Grasing K
Neurochem Res; 1999 Jan; 24(1):95-107. PubMed ID: 9973242
[TBL] [Abstract][Full Text] [Related]
11. Effect of precipitated withdrawal on extracellular glutamate and aspartate in the nucleus accumbens of chronically morphine-treated rats: an in vivo microdialysis study.
Sepulveda MJ; Hernandez L; Rada P; Tucci S; Contreras E
Pharmacol Biochem Behav; 1998 May; 60(1):255-62. PubMed ID: 9610950
[TBL] [Abstract][Full Text] [Related]
12. Aquaporin-4 deficiency attenuates opioid dependence through suppressing glutamate transporter-1 down-regulation and maintaining glutamate homeostasis.
Yan HT; Wu N; Lu XQ; Su RB; Zheng JQ; Li J
CNS Neurosci Ther; 2013 Jan; 19(1):12-9. PubMed ID: 23051665
[TBL] [Abstract][Full Text] [Related]
13. Dopamine-dependent increases in phosphorylation of cAMP response element binding protein (CREB) during precipitated morphine withdrawal in primary cultures of rat striatum.
Chartoff EH; Papadopoulou M; Konradi C; Carlezon WA
J Neurochem; 2003 Oct; 87(1):107-18. PubMed ID: 12969258
[TBL] [Abstract][Full Text] [Related]
14. Regulation of glutamate transporter GLAST and GLT-1 expression in astrocytes by estrogen.
Pawlak J; Brito V; Küppers E; Beyer C
Brain Res Mol Brain Res; 2005 Jul; 138(1):1-7. PubMed ID: 15896872
[TBL] [Abstract][Full Text] [Related]
15. Role of the GLT-1 subtype of glutamate transporter in glutamate homeostasis: the GLT-1-preferring inhibitor WAY-855 produces marginal neurotoxicity in the rat hippocampus.
Selkirk JV; Nottebaum LM; Vana AM; Verge GM; Mackay KB; Stiefel TH; Naeve GS; Pomeroy JE; Petroski RE; Moyer J; Dunlop J; Foster AC
Eur J Neurosci; 2005 Jun; 21(12):3217-28. PubMed ID: 16026460
[TBL] [Abstract][Full Text] [Related]
16. [Involvement of the amygdala on place aversion induced by naloxone in single-dose morphine-treated rats].
Ishida S; Shimosaka R; Kawasaki Y; Jin C; Kitamura Y; Araki H; Sendo T; Gomita Y
Yakugaku Zasshi; 2008 Mar; 128(3):395-403. PubMed ID: 18311059
[TBL] [Abstract][Full Text] [Related]
17. Astrocytes repress the neuronal expression of GLAST and GLT glutamate transporters in cultured hippocampal neurons from embryonic rats.
Plachez C; Martin A; Guiramand J; Récasens M
Neurochem Int; 2004 Dec; 45(7):1113-23. PubMed ID: 15337311
[TBL] [Abstract][Full Text] [Related]
18. Effects of harman and harmine on naloxone-precipitated withdrawal syndrome in morphine-dependent rats.
Aricioglu-Kartal F; Kayir H; Tayfun Uzbay I
Life Sci; 2003 Sep; 73(18):2363-71. PubMed ID: 12941438
[TBL] [Abstract][Full Text] [Related]
19. Co-administration of ultra-low dose naloxone attenuates morphine tolerance in rats via attenuation of NMDA receptor neurotransmission and suppression of neuroinflammation in the spinal cords.
Lin SL; Tsai RY; Shen CH; Lin FH; Wang JJ; Hsin ST; Wong CS
Pharmacol Biochem Behav; 2010 Aug; 96(2):236-45. PubMed ID: 20478329
[TBL] [Abstract][Full Text] [Related]
20. Neurotoxic and neuroprotective effects of the glutamate transporter inhibitor DL-threo-beta-benzyloxyaspartate (DL-TBOA) during physiological and ischemia-like conditions.
Bonde C; Sarup A; Schousboe A; Gegelashvili G; Zimmer J; Noraberg J
Neurochem Int; 2003; 43(4-5):371-80. PubMed ID: 12742081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
